Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

Human Molecular Genetics

Volumn 13, Issue 16, 2004, Pages 1745-1754

  Jiang, Houbo ^a   Ren, Yong ^a   Zhao, Jinghui ^a   Feng, Jian ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CASPASE 3; DOPAMINE; DOPAMINE TRANSPORTER; HYDROGEN PEROXIDE; LIGASE; PARKIN; REACTIVE OXYGEN METABOLITE; ROTENONE; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN;

APOPTOSIS; ARTICLE; CARBONYLATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENE MUTATION; GENE OVEREXPRESSION; HEREDITY; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NEUROBLASTOMA CELL; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; DOPAMINE; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; ROTENONE; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASES;

EID: 4444327827     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh180     Document Type: Article

References (36)

1. Langston, J.W. (2002) Parkinson's disease: current and future challenges. Neurotoxicology, 23, 443-450.
2. Dekker, M.C., Bonifati, V. and van Duijn, C.M. (2003) Parkinson's disease: piecing together a genetic jigsaw. Brain, 126, 1722-1733.
3. Oliveira, S.A., Scott, W.K., Martin, E.R., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R., Stem, M.B., Hiner, B.C. et al. (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann. Neurol., 53, 624-629.
4. Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A., Hiner, B.C. et al. (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. J. Am. Med. Assoc., 286, 2239-2244.
5. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000) Familial Parkinson disease gene product, Parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
6. Feng, J. (2003) Genetic factors in Parkinson's disease and potential therapeutic targets. Curr. Neuropharm., 1, 301-313.
7. Hastings, T.G., Lewis, D.A. and Zigmond, M.J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl Acad. Sci. USA, 93, 1956-1961.
8. Luo, Y.Q., Umegaki, H., Wang, X.T., Abe, R. and Roth, G.S. (1998) Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem., 273, 3756-3764.
9. Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A. and Davis, R.J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science, 288, 870-874.
10. Budihardjo, I., Oliver, H., Lutter, M., Luo, X. and Wang, X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol., 15, 269-290.
11. Wang, H., Shimoji, M., Yu, S.W., Dawson, T.M. and Dawson, V.L. (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann. NY Acad. Sci., 991, 132-139.
12. Jenner, P. and Olanow, C.W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology, 47, S161-S170.
13. Ren, Y., Zhao, J.H. and Feng, J. (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J. Neurosci., 23, 3316-3324.
14. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. (2001) Ubiquitination of a new form of alpha-synuclein by Parkin from human brain: implications for Parkinson's disease. Science, 293, 263-269.
15. Finney, N., Walther, F., Mantel, P.Y., Stauffer, D., Rovelli, G. and Dev, K.K. (2003) The cellular protein level of Parkin is regulated by its ubiquitin-like domain. J. Biol. Chem., 278, 16054-16058.
16. Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., Yokosawa, H., Hattori, N., Mizuno, Y. et al. (2003) Parkin binds the Rpn 10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep., 4, 301-306.
17. Poewe, W.H. and Wenning, G.K. (1998) The natural history of Parkinson's disease. Ann. Neurol., 44, S1-S9.
18. Carlsson, A. (2001) A paradigm shift in brain research. Science, 294, 1021-1024.
19. Jeon, B.S., Jacksonlewis, V. and Burke, R.E. (1995) 6-Hydroxydopamine lesion of the rat substantia-nigra - time-course and morphology of cell-death. Neurodegeneration, 4, 131-137.
20. Langston, J.W., Ballard, P., Tetrud, J.W. and Irwin, I. (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219, 979-980.
21. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci., 3, 1301-1306.
22. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
23. Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M., Soengas, M.S., Elia, A., de la Pompa, J.L., Kagi, D., Khoo, W. et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94, 339-352.
24. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
25. Mandir, A.S., Przedborski, S., Jackson-Lewis, V., Wang, Z.Q., Simbulan-Rosenthal, C.M., Smulson, M.E., Hoffman, B.E., Guastella, D.B., Dawson, V.L. and Dawson, T.M. (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl Acad. Sci. USA, 96, 5774-5779.
26. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.
27. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144-1150.
28. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet., 12, 1427-1437.
29. Khan, N.L., Graham, E., Critchley, P., Schrag, A.E., Wood, N.W., Lees, A.J., Bhatia, K.P. and Quinn, N. (2003) Parkin disease: a phenotypic, study of a large case series. Brain, 126, 1279-1292.
30. Itier, J.M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L. et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet., 12, 2277-2291.
31. Hyun, D.H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B. and Jenner, P. (2002) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J. Biol. Chem., 277, 28572-28577.
32. Petrucelli, L., O'Farrell, C., Lockhart, P.J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. et al. (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron, 36, 1007-1019.
33. Muqit, M.M., Davidson, S.M., Payne, S., MacCormac, L.P., Kahns, S., Jensen, P.H., Wood, N.W. and Latchman, D.S. (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum. Mol. Genet., 13, 117-135.
34. Darios, F., Corti, O., Lucking, C.B., Hampe, C., Muriel, M.P., Abbas, N., Gu, W.J., Hirsch, E.C., Rooney, T., Ruberg, M. et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet., 12, 517-526.
35. Zhao, J., Ren, Y., Jiang, Q. and Feng, J. (2003) Parkin is recruited to the centrosome in response to inhibition of proteasomes. J. Cell Sci., 116, 4011-4019.
36. Larsen, K.E., Fon, E.A., Hastings, T.G., Edwards, R.H. and Sulzer, D. (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci., 22, 8951-8960.